Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment

Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment

IntroductionThe clinical significance of persistent positive in Hepatitis B Virus (HBV) DNA level in patients receiving antiviral therapy is not well known. We investigated factors associated with persistent viremia (PV) in patients with chronic hepatitis B (CHB) given 78-week entecavir.MethodsA tot...

Full description

Bibliographic Details
Main Authors:	Jun Li, Xiao-Qin Dong, Li-Hua Cao, Zhan-Qing Zhang, Wei-Feng Zhao, Qing-Hua Shang, Da-Zhi Zhang, An-Lin Ma, Qing Xie, Hong-Lian Gui, Guo Zhang, Ying-Xia Liu, Jia Shang, Shi-Bin Xie, Yi-Qi Liu, Chi Zhang, Gui-Qiang Wang, Hong Zhao, China HepB Related Fibrosis Assessment Research Group
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	chronic hepatitis B persistant viremia HBV DNA anti-hepatitis B virus core antibody fibrosis carcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1151899/full

Similar Items

Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage?
by: Ercan Yenilmez, et al.
Published: (2018-08-01)

Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels
by: Faisal M Sanai, et al.
Published: (2022-01-01)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
by: Mary C. Kuhns, et al.
Published: (2021-10-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study
by: Qian Yang, et al.
Published: (2024-03-01)

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
by: Byung-Cheol Song, et al.
Published: (2014-12-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
by: Yu-Chan Yang, et al.
Published: (2021-12-01)

Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B
by: Wei Zhang, et al.
Published: (2022-11-01)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
by: Chih-Wei Tseng, et al.
Published: (2022-08-01)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-01-01)

Low positivity rates for HBeAg and HBV DNA in rheumatoid arthritis patients: a case–control study
by: Yue Jia, et al.
Published: (2022-06-01)

Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B
by: Shun Ishido, et al.
Published: (2023-08-01)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
by: Cesare Mazzaro, et al.
Published: (2022-10-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

The role of different viral biomarkers on the management of chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-04-01)

Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma
by: Qingquan Bai, et al.
Published: (2023-12-01)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas<sup>®</sup> HBV Test for Use on the Cobas<sup>®</sup> 4800 System
by: Valérie Ortonne, et al.
Published: (2021-03-01)

NGS amplification panel for HBV (Hepadnaviridae: <i>Orthohepadnavirus</i>) sequencing
by: Mikhail D. Chanyshev, et al.
Published: (2024-03-01)

The Role of Autophagy in the Mother-to-Child Transmission of Pregnant Women With a High Level of HBV DNA
by: Hong Gao, et al.
Published: (2022-04-01)

Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
by: Bei Jiang, et al.
Published: (2022-12-01)

Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination
by: Fedor A. Asadi Mobarkhan, et al.
Published: (2023-02-01)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
by: Shaowen Jiang, et al.
Published: (2023-01-01)

Diagnostic precision of Truenat® technique and co-relation of ALT levels with HBV-DNA viral load among HBsAg positive patients at a tertiary care hospital in Eastern Uttar Pradesh
by: Sarita Kumari, et al.
Published: (2024-02-01)

Early and late recurrence after hepatectomy in patients with low-level HBV-DNA hepatocellular carcinoma under antiviral therapy
by: Ziqiang Li, et al.
Published: (2022-11-01)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing? [version 1; peer review: 1 approved, 2 approved with reservations]
by: Tingyan Wang, et al.
Published: (2022-08-01)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing? [version 2; peer review: 1 approved, 2 approved with reservations]
by: Tingyan Wang, et al.
Published: (2023-03-01)

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy
by: Shida Pan, et al.
Published: (2022-05-01)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
by: Selena Y. Lin, et al.
Published: (2021-05-01)

Characterization of Hepatitis B Virus and Human Immunodeficiency Virus among HIV/HBV Co-Infected Patients from the Republic of Guinea
by: A. N. Shchemelev, et al.
Published: (2019-10-01)

Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
by: Karen K. Kyuregyan, et al.
Published: (2021-01-01)

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
by: Valentina Svicher, et al.
Published: (2023-03-01)

HBV-Integration Studies in the Clinic: Role in the Natural History of Infection
by: Teresa Pollicino, et al.
Published: (2021-02-01)

Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country
by: Erwin Ho, et al.
Published: (2024-03-01)

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
by: Ya-Li Zhang, et al.
Published: (2019-01-01)

A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets
by: Daqiong Zhou, et al.
Published: (2024-02-01)

Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
by: Mariantonietta Di Stefano, et al.
Published: (2023-02-01)

High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable
by: Chengwei Wang, et al.
Published: (2023-05-01)

Canonical and Divergent N-Terminal HBx Isoform Proteins Unveiled: Characteristics and Roles during HBV Replication
by: Sergio Hernández, et al.
Published: (2021-11-01)